68Ga-PSMA-617 PET/CT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-PSMA-617 PET/CT, covering 2020-06-11 to 2020-06-11. Get the full timeline:
Most recent: Clinical Trial Update: 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks [Phase 2]